Mohammad B. Haskali

1.2k total citations
39 papers, 380 citations indexed

About

Mohammad B. Haskali is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology and Molecular Biology. According to data from OpenAlex, Mohammad B. Haskali has authored 39 papers receiving a total of 380 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Radiology, Nuclear Medicine and Imaging, 17 papers in Oncology and 10 papers in Molecular Biology. Recurrent topics in Mohammad B. Haskali's work include Radiopharmaceutical Chemistry and Applications (24 papers), Peptidase Inhibition and Analysis (12 papers) and Prostate Cancer Treatment and Research (9 papers). Mohammad B. Haskali is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (24 papers), Peptidase Inhibition and Analysis (12 papers) and Prostate Cancer Treatment and Research (9 papers). Mohammad B. Haskali collaborates with scholars based in Australia, United States and Austria. Mohammad B. Haskali's co-authors include Victor W. Pike, Peter Roselt, Rodney J. Hicks, Craig A. Hutton, Sanjay Telu, Cheryl L. Morse, Carleen Cullinane, Paul S. Donnelly, Kelly Waldeck and Lachlan E. McInnes and has published in prestigious journals such as Angewandte Chemie International Edition, Journal of Clinical Oncology and Scientific Reports.

In The Last Decade

Mohammad B. Haskali

35 papers receiving 380 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mohammad B. Haskali Australia 12 201 106 104 86 78 39 380
Gemma Dias United Kingdom 11 194 1.0× 116 1.1× 147 1.4× 35 0.4× 51 0.7× 21 347
Louis Allott United Kingdom 11 306 1.5× 89 0.8× 145 1.4× 33 0.4× 57 0.7× 28 420
Jerome Lozada Canada 9 151 0.8× 113 1.1× 69 0.7× 74 0.9× 165 2.1× 16 356
Fadi Zarrad Germany 10 239 1.2× 120 1.1× 274 2.6× 152 1.8× 85 1.1× 19 583
Timo Stellfeld Germany 14 346 1.7× 279 2.6× 202 1.9× 156 1.8× 206 2.6× 19 729
Andreas Bauman Switzerland 12 256 1.3× 181 1.7× 211 2.0× 26 0.3× 197 2.5× 17 573
P.A. Schubiger Switzerland 7 301 1.5× 75 0.7× 141 1.4× 23 0.3× 87 1.1× 9 388
Ola Åberg Sweden 13 128 0.6× 131 1.2× 111 1.1× 49 0.6× 74 0.9× 21 347
Magne Solbakken Norway 10 263 1.3× 171 1.6× 98 0.9× 42 0.5× 103 1.3× 14 428
Drishty Satpati India 12 318 1.6× 91 0.9× 186 1.8× 11 0.1× 43 0.6× 50 428

Countries citing papers authored by Mohammad B. Haskali

Since Specialization
Citations

This map shows the geographic impact of Mohammad B. Haskali's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mohammad B. Haskali with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mohammad B. Haskali more than expected).

Fields of papers citing papers by Mohammad B. Haskali

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mohammad B. Haskali. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mohammad B. Haskali. The network helps show where Mohammad B. Haskali may publish in the future.

Co-authorship network of co-authors of Mohammad B. Haskali

This figure shows the co-authorship network connecting the top 25 collaborators of Mohammad B. Haskali. A scholar is included among the top collaborators of Mohammad B. Haskali based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mohammad B. Haskali. Mohammad B. Haskali is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sutherland, G. R., Evelyn Tsantikos, Bianca Jupp, et al.. (2025). Early microglia-mediated neuroinflammation after status epilepticus causes behavioral dysfunction and neurocognitive deficits but not epilepsy in mice. Brain Behavior and Immunity. 131. 106183–106183.
2.
Kostos, Louise, James P Buteau, Grace Kong, et al.. (2025). Clinical Trial Protocol for LuCAB: A Phase I–II Trial Evaluating Cabazitaxel in Combination with [177Lu]Lu-PSMA-617 in Patients with Metastatic Castration-Resistant Prostate Cancer. Journal of Nuclear Medicine. 66(4). 572–578. 3 indexed citations
3.
Roselt, Peter, et al.. (2025). A scalable protocol for the radiosynthesis of clinical grade lutetium-177-labeled theranostic agents. Nature Protocols. 21(1). 60–78. 3 indexed citations
4.
5.
Corlett, Alicia, Marc‐Antoine Sani, Benjamin J. Blyth, et al.. (2024). Precision peptide theranostics: developing N- to C-terminus optimized theranostics targeting cholecystokinin-2 receptor. Theranostics. 14(5). 1815–1828.
6.
Buteau, James P, Louise Kostos, Ramin Alipour, et al.. (2024). Clinical Trial Protocol for VIOLET: A Single-Center, Phase I/II Trial Evaluation of Radioligand Treatment in Patients with Metastatic Castration-Resistant Prostate Cancer with [161Tb]Tb-PSMA-I&T. Journal of Nuclear Medicine. 65(8). 1231–1238. 11 indexed citations
7.
Telu, Sanjay, Mohammad B. Haskali, Qunchao Zhao, et al.. (2023). Broad‐scope Syntheses of [11C/18F]Trifluoromethylarenes from Aryl(mesityl)iodonium Salts. Chemistry - A European Journal. 29(24). e202204004–e202204004. 10 indexed citations
8.
Haskali, Mohammad B., et al.. (2021). Radiolabelled Peptides: Optimal Candidates for Theranostic Application in Oncology. Australian Journal of Chemistry. 75(2). 34–54. 8 indexed citations
9.
Noor, Asif, Stacey E. Rudd, Peter Roselt, et al.. (2021). Imaging Somatostatin Positive Tumors with Tyr3-Octreotate/Octreotide Conjugated to Desferrioxamine B Squaramide Radiolabeled with either Zirconium-89 or Gallium-68. Bioconjugate Chemistry. 32(7). 1192–1203. 8 indexed citations
10.
Vivash, Lucy, Ramesh Mudududdla, Nghi Nguyen, et al.. (2021). Development of [18F]MIPS15692, a radiotracer with in vitro proof-of-concept for the imaging of MER tyrosine kinase (MERTK) in neuroinflammatory disease. European Journal of Medicinal Chemistry. 226. 113822–113822. 6 indexed citations
11.
Lee, Jae‐Hoon, Mattia Veronese, Jeih‐San Liow, et al.. (2021). Region- and voxel-based quantification in human brain of [18F]LSN3316612, a radioligand for O-GlcNAcase. EJNMMI Research. 11(1). 35–35. 3 indexed citations
12.
13.
Lee, Jae‐Hoon, Jeih‐San Liow, Soumen Paul, et al.. (2020). PET quantification of brain O-GlcNAcase with [18F]LSN3316612 in healthy human volunteers. EJNMMI Research. 10(1). 20–20. 21 indexed citations
14.
Haskali, Mohammad B., et al.. (2020). Gallium Fluoride Complexes with Acyclic Bispicolinic Ligands as Potential New Fluorine‐18 Labelled Imaging Agents. European Journal of Inorganic Chemistry. 2020(35). 3378–3386. 4 indexed citations
15.
Cullinane, Carleen, Kelly Waldeck, Lachlan E. McInnes, et al.. (2019). A Bivalent Inhibitor of Prostate Specific Membrane Antigen Radiolabeled with Copper‐64 with High Tumor Uptake and Retention. Angewandte Chemie. 131(42). 15133–15136. 1 indexed citations
16.
Cullinane, Carleen, Kelly Waldeck, Lachlan E. McInnes, et al.. (2019). A Bivalent Inhibitor of Prostate Specific Membrane Antigen Radiolabeled with Copper‐64 with High Tumor Uptake and Retention. Angewandte Chemie International Edition. 58(42). 14991–14994. 46 indexed citations
17.
Telu, Sanjay, et al.. (2019). A Gas Phase Route to [18F]fluoroform with Limited Molar Activity Dilution. Scientific Reports. 9(1). 14835–14835. 21 indexed citations
18.
Haskali, Mohammad B., et al.. (2019). Automated preparation of clinical grade [68Ga]Ga-DOTA-CP04, a cholecystokinin-2 receptor agonist, using iPHASE MultiSyn synthesis platform. EJNMMI Radiopharmacy and Chemistry. 4(1). 23–23. 6 indexed citations
19.
Haskali, Mohammad B., Delphine Denoyer, Peter Roselt, Rodney J. Hicks, & Craig A. Hutton. (2019). Radiosynthesis and preliminaryin vivoevaluation of18F-labelled glycosylated duramycin peptides for imaging of phosphatidylethanolamine during apoptosis. MedChemComm. 10(11). 1930–1934. 3 indexed citations
20.
Paul, Soumen, Mohammad B. Haskali, Jeih-San Liow, et al.. (2018). Evaluation of a PET Radioligand to Image O-GlcNAcase in Brain and Periphery of Rhesus Monkey and Knock-Out Mouse. Journal of Nuclear Medicine. 60(1). 129–134. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gemma Dias Breakdown of academic impact, for papers by Louis Allott Breakdown of academic impact, for papers by Jerome Lozada Breakdown of academic impact, for papers by Fadi Zarrad Breakdown of academic impact, for papers by Timo Stellfeld Breakdown of academic impact, for papers by Andreas Bauman Breakdown of academic impact, for papers by P.A. Schubiger Breakdown of academic impact, for papers by Ola Åberg Breakdown of academic impact, for papers by Magne Solbakken Breakdown of academic impact, for papers by Drishty Satpati
Rankless by CCL
2026